This study evaluated the clinical effectiveness of low-frequency pulsed electromagnetic field (PEMF) therapy for women with fibromyalgia (FM). Fifty-six women with FM, aged 18 to 60 years, were randomly assigned to either PEMF or sham therapy. Both the PEMF group (n=28) and the sham group (n=28) participated in therapy, 30 minutes per session, twice a day for 3 weeks. Treatment outcomes were assessed by the fibromyalgia Impact questionnaire (FIQ), visual analog scale (VAS), patient global assessment of response to therapy, Beck Depression Inventory (BDI), and Short-Form 36 health survey (SF-36), after treatment (at 4 wk) and follow-up (at 12 wk).
The PEMF group showed significant improvements in FIQ, VAS pain, BDI score, and SF-36 scale in all domains at the end of therapy. These improvements in FIQ, VAS pain, and SF-36 pain score during follow-up. The sham group also showed improvement were maintained on all outcome measures except total FIQ scores after treatment. At 12 weeks follow-up, only improvements in the BDI and SF-36 scores were present in the sham group. In conclusion, this study showed that low-frequency PEMF therapy might improve function, pain, fatigue, and global status in FM patients.
Sutbeyaz, Serap Tomruk MD; Sezer, Nebahat MD; Koseoglu, Fusun MD; Kibar, Sibel MD Low-frequency Pulsed Electromagnetic Field Therapy in Fibromyalgia, The Clinical Journal of Pain: October 2009 – Volume 25 – Issue 8 – p 722-728 doi: 10.1097/AJP.0b013e3181a68a6c
